Dr. Paul Kwon

Chief Medical Officer

From 2010 to 2015, Dr. Kwon was Chief Medical Officer at Nora Therapeutics from, a biotechnology company focused on developing therapeutics to address significant unmet needs in reproductive medicine.

At Nora, he led development of a clinical-stage molecule for the treatment of repeated implantation failure and recurrent miscarriage.

From 2003 to 2009, Dr. Kwon held numerous positions at Genentech, where he was most recently head of the nononcology early clinical development group and oversaw clinical development of molecules from pre-IND through phase 2 in multiple therapeutic areas, including rheumatology, neurology, cardiovascular disease and ophthalmology.

In addition, he managed the medical groups for two post-marketed franchises in cardiovascular and metabolic disease.

Dr. Kwon was in clinical practice as a dermatologist from 2001 to 2003 and 2009 to 2010 with the Permanente Medical Group in Northern California, where he also served as a consultant for the Permanente Technology Group.

Prior to this position, he was product manager and later director of business development for iMedica Corp, a healthcare IT firm in Mountain View, CA.

From 2004 to 2014, Dr. Kwon served on the faculty at the University of California at San Francisco as Assistant Clinical Professor of Dermatology.

Dr. Kwon received his B.A. in human biology from Stanford University, and his M.D. from the University of California at San Francisco. He is a diplomate of the American Board of Dermatology and a fellow of the American Academy of Dermatology.

Category Leadership

Date 6 March 2017